Skip to content
Recall Observatory FDA recall evidence

Drug product

DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79

D-0526-2020

November 06, 2019

Class II

Product summary

Firm
AuroMedics Pharma LLC
Event
Event 84218
Status
Ongoing
Classification
Class II
Quantity
69,696 bottles
Official record key
drug-enforcement:D-0526-2020

Official wording

Reason: CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.

Code information: Lot # NBSB19001DA3; Exp FEB 2021

Distribution pattern: nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations